Progenitors for the Corneal Endothelium and Trabecular Meshwork: A Potential Source for Personalized Stem Cell Therapy in Corneal Endothelial Diseases and Glaucoma

<table>After 7 days of differentiation, cells derived from the spheres also expressed <i>β</i>-III tubulin. Nuclei were counterstained with DAPI (blue). The inset is a negative control with nonimmunized IgG. Scale bar = 50 <i>μ</i>m.</table>

BioMed Research International

fig5

Figure 5

Figure 5: Progenitors for the Corneal Endothelium and Trabecular Meshwork: A Potential Source for Personalized Stem Cell Therapy in Corneal Endothelial Diseases and Glaucoma 

Figure 5 | Progenitors for the Corneal Endothelium and Trabecular Meshwork: A Potential Source for Personalized Stem Cell Therapy in Corneal Endothelial Diseases and Glaucoma 